Abstract P-542

pp. 515-542 Zanfei 937

It is suggested that a transition is taking place towards new modes of organising transnational corporations’ innovative activities. First, different units of multinational firms, including foreign-based subsidiaries, are increasingly involved in the generation, use and transmission of knowledge. Secondly, multinationals are developing external networks of relationships with local counterparts,...

Technology evaluation: PRO-542, Progenics Pharmaceuticals inc.

Progenics's rCD4-IgG2 (PRO-542) is a recombinant fusion protein, which has been developed using the company's Universal Antiviral Binding (UnAB) technology, and is in phase I/II clinical trials for the treatment of human immunodeficiency virus type I (HIV-1) infection [273391]. At the beginning of 1997, Progenics received a Phase II Small Business Innovation Research Program (SBIR) grant from t...

542 Calculations of Potentials in Nitella

In earlier studies 1 the electrical behavior of Nitella conformed to the equat ions of Nerns t and of Henderson bu t recently, in a different set of cells, ~ we have found some appa ren t exceptions. These exceptions are i l lustrated in Fig. 1. The theoret ical curve shows the approx imate change in P.D. which KC1 would produce if the values were due entirely to diffusion potent ia l in the pr...

542 Archives of Disease in Childhood

Since hypophosphatasia was first described (Rathbun, 1948), other cases which have been recognized have raised the possibility that this defect of alkaline phosphatase is an inherited inborn error of metabolism. Schneider and Corcoran (1950) first suggested that this was an inherited disorder when two cases were found in one family, and this was corroborated by Sobel, Clark, Fox and Robinow (19...

abstract